BioLife Solutions Inc (BLFS)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 50,311 48,586 30,537 33,803 36,073 9,913 34,583 -30,706 -28,315 8,564 3,960 71,723 62,547 64,476 48,166 29,462 23,366 -7,891 -3,845 840
Revenue (ttm) US$ in thousands 102,868 122,972 125,729 136,909 142,796 154,008 161,427 162,452 161,032 154,468 147,521 138,192 118,837 96,581 74,057 52,773 48,087 41,249 36,673 33,590
Gross profit margin 48.91% 39.51% 24.29% 24.69% 25.26% 6.44% 21.42% -18.90% -17.58% 5.54% 2.68% 51.90% 52.63% 66.76% 65.04% 55.83% 48.59% -19.13% -10.48% 2.50%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $50,311K ÷ $102,868K
= 48.91%

BioLife Solutions Inc's gross profit margin has fluctuated over the past few years, with some periods showing negative margins. The trend in the most recent quarters indicates an improvement in profitability, with margins increasing from around 50% to close to 50% at the end of 2024. While there have been periods of low margins, the company has managed to increase its profitability over time. It is essential for the company to sustain this positive trend to ensure long-term financial health and growth.